Insulin-like growth factor system in neuroblastoma tumorigenesis and apoptosis: Potential diagnostic and therapeutic perspectives

Hormone and Metabolic Research

Volumn 31, Issue 2-3, 1999, Pages 138-141

  Zumkeller, Walter ^a   Schwab, M ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; IGF binding proteins; Insulin like growth factors; Neuroblastoma

Indexed keywords

DNA; ETOPOSIDE; GROWTH FACTOR; MANNOSE 6 PHOSPHATE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; POTASSIUM; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN TYROSINE KINASE; PROTEINASE; RETINOIC ACID; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN RECEPTOR; SURAMIN; TAU INTERFERON; TISSUE PLASMINOGEN ACTIVATOR;

APOPTOSIS; ARTICLE; CARCINOGENESIS; GENE THERAPY; HUMAN; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL;

EID: 0032956730     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978711     Document Type: Article

References (57)

1. 1. Brodeur GM, Castleberry RP. Neuroblastoma. In: Pizzo PA, Poplack DG (eds). Principles and practice of pediatric oncology, 2nd ed. Philadelphia, Lippincott 1993: 739-67
2. 2. Schwab M, Joshi V. Neuroblastic tumours of the adrenal gland and sympathetic nervous system. In: Kleihues P, Cavenee WK (eds). Pathology and genetics of tumours of the nervous system. Lyon, International Agency for Research on Cancer 1997: 117-23
3. 3. Evans AE. Natural history of neuroblastoma. In: Evans AE (ed). Advances in neroblastoma research. New York, Raven Press 1980: 3
4. 4. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994; 78: 539-42
5. 5. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T. p53 status and the efficacy of cancer therapy in vivo. Science 1994; 266: 807-10
6. 6. Påhlman S, Meyerson G, Lindgren E, Schalling M, Johansson I. Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation. Proc Natl Acad Sci USA 1991 ; 88: 9994-8
7. 7. Sumantran VN, Feldman EL. Insulin-like growth factor I regulates c-myc and GAP-43 messenger ribonucleic acid expression in SH-SY5Y human neuroblastoma cells. Endocrinology 1993; 132: 2017-23
8. 8. D'Mello SR, Galli C, Ciotti T, Calissano P. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci USA 1993; 90: 10989-93
9. 9. Parrizas M, Le Roith D. Insulin-like growth factor-I inhibition of apoptosis is associated with increased expression of the bcl-xL gene product. Endocrinology 1997; 138: 1355-8
10. 10. Singleton JR, Randolph AE, Feldman EL. Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. Cancer Res 1996; 56: 4522-9
11. 11. Zhang L, Kashanchi F, Zhan Q, Zhan S, Brady JN, Fornace AJ, Seth P, Helman LJ. Regulation of insulin-like growth factor II P3 promoter by p53: a potential mechanism for tumorigenesis. Cancer Res 1996; 56: 1367-73
12. 12. Zhang L, Zhan Q, Zhan S, Kashanchi F, Fornace AJ Jr, Seth P, Helman LJ. p53 regulates human insulin-like growth factor II gene expression through active P4 promoter in rhabdomyosarcoma cells. DNA Cell Biol 1998; 17: 125-31
13. 13. Ohlsson C, Kley N, Werner H, LeRoith D. p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1. Endocrinology 1998; 139: 1101-7
14. 14. Lamm GM, Christofori G. Impairment of survival factor function potentiates chemotherapy-induced apoptosis in tumor cells. Cancer Res 1998; 58: 801-7
15. 15. Sullivan KA, Castle VP, Hanash SM, Feldman EL. Insulin-like growth factor II in the pathogenesis of human neuroblastoma. Am J Pathol 1995; 147: 1790-8
16. 16. Matthews CC, Feldman EL. Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death. J Cell Physiol 1996; 166: 323-31
17. 17. van Golen CM, Feldman EL. Insulin-like growth factor I's effect on caspase activation in human neuroblastoma. Proc Am Assoc Cancer Res 1998; 39: 577
18. 18. Werner H, LeRoith D. The insulin-like growth factor-I receptor signalling pathways are important for tumorigenesis and inhibition of apoptosis. Crit Rev Oncogenesis 1997; 8: 71-92
19. 19. Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R, Rubin R. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-I (IGF-I) receptor are nontumorigenic and induce regression of wildtype tumors. Cancer Res 1994; 54: 2218-22
20. 20. Baserga R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 1995; 55: 249-52
21. 21. Macauley VM. Insulin-like growth factors and cancer. Br J Cancer 1992; 65: 311-20
22. 22. Harrington EA, Bennett MR, Fanidi A, Evan GI. c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 1994; 13: 3286-95
23. 23. Kaufmann-Zeh, Rodriquez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, Evan G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 1997; 385: 544-8
24. 24. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 231-41
25. 25. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997; 275: 661-5
26. 26. Dennis PA, Kastan MB. Kinase inhibitors abrogate growth factor protection from irradiation induced apoptosis in neuroblastoma cells. Proc Am Assoc Cancer Res 1998; 39: 145
27. 27. Liu JP, Baker J, Perkin AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993; 75: 59-72
28. 28. Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1997; 1332: F105-F126
29. 29. Rininsland F, Johnson TR, Chernicky CL, Schulze E, Burfeind P, Ilan J. Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells. Proc Natl Acad Sci USA 1997; 94: 5854-9
30. 30. O'Connor R, Kauffmann-Zeh A, Liu Y, Lehar S, Evan GI, Baserga R, Blattler WA. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol Cell Biol 1997; 17: 427-35
31. 31. Prior TI, Helman LJ, FitzGerald DJ, Pastan I. Cytotoxic activity of a recombinant fusion protein between insulin-like growth factor I and Pseudomonas exotoxin. Cancer Res 1991 ; 51: 174-80
32. 32. Sullivan KA, Kim B, Buzdon M, Feldman EL. Suramin disrupts insulin-like growth factor II (IGF-II) mediated autocrine growth in human SH-SY5Y neuroblastoma cells. Brain Res 1997; 744: 199-206
33. 33. Martin DM, Carlson RO, Feldman EL. Interferon-gamma inhibits DNA synthesis and insulin-like growth factor-II expression in human neuroblastoma cells. J Neurosci Res 1993; 34: 489-501
34. 34. Matsumoto K, Gaetano C, Daughaday WH, Thiele CJ. Retinoic acid regulates insulin-like growth factor II expression in a neuroblastoma cell line. Endocrinology 1992; 130: 3669-76
35. 35. Ueno T, Suita S, Zaizen Y. Retinoic acid induces insulin-like growth factor II expression in a neuroblastoma cell line. Cancer Lett 1993; 71: 177-82
36. 36. Kang JX, Li Y, Leaf A. Mannose-6-phosphate/insulin-like growth factor II receptor is a receptor for retinoic acid. Proc Natl Acad Sci USA 1997; 94: 13671-6
37. 37. Menouny M, Binoux M, Babajko S. Role of insulin-like growth factor binding protein-2 and its limited proteolysis in neuroblastoma cell proliferation: modulation by transforming growth factor-beta and retinoic acid. Endocrinology 1997; 138: 683-90
38. 38. Babajko S, Leneuve P, Loret C, Binoux M. IGFBP-6 is involved in growth inhibition in SH-SY5Y human neuroblastoma cells. Its production is both IGF- and cell density-dependent. J Endocrinol 1997; 152: 221-7
39. 39. Babajko S, Binoux M. Modulation by retinoic acid of insulin-like growth factor (IGF) and IGF binding protein expression in human SK-N-SH neuroblastoma cells. Eur J Endocrinol 1996; 134: 474-80
40. 40. Grellier P, De Galle B, Babajko S. Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth. Cancer Res 1998; 58: 1670-6
41. 41. Trojan J, Blossey BK, Johnson TR, Rudin SD, Tykocinski M, Ilan J, Ilan J. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc Natl Acad Sci USA 1992; 89: 4874-8
42. 42. Trojan J, Johnson TR, Rudin SD, Ilan J, Tykocinski ML, Ilan J. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science 1993; 259: 94-7
43. 43. Lafarge-Frayssinet C, Duc HT, Frayssinet C, Sarasin A, Anthony D, Guo Y, Trojan J. Antisense insulin-like growth factor I transferred into a rat hepatoma cell line inhibits tumorigenesis by modulating major histocompatibility complex I cell surface expression. Cancer Gene Ther 1997; 4: 276-85
44. 44. Wang ZH, Ma J, Zeng BJ, Catanese VM, Samuels S, Gama-Sosa MA, Kolodny EH. Correlation of glioma cell regression with inhibition of insulin-like growth factor I and insulin-like growth factor-binding protein-2 expression. Neuroendocrinology 1997; 66: 203-11
45. 45. Shevelev A, Burfeind P, Schulze E, Rininsland F, Johnson TR, Trojan J, Chermicky CL, Helene C, Ilan J, Ilan J. Potential triple helix-mediated inhibition of IGF-I gene expression significantly reduces tumorigenicity of glioblastoma in an animal model. Cancer Gene Ther 1997; 4: 105-12
46. 46. Barletta JM, Rainier S, Feinberg AP. Reversal of loss of imprinting in tumor cells by 5-aza-2′-deoxycytidine. Cancer Res 1997; 57: 48-50
47. 47. Ambrose D, Resnicoff M, Coppola D, Sell C, Miura M, Jameson S, Baserga R, Rubin R. Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-I and its receptor. J Cell Physiol 1994; 159: 92-100
48. 48. Lee CT, Wu S, Gabrilovich D, Chen H, Nadaf-Rahrov S, Ciernik IF, Carbone DP. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines. Cancer Res 1996; 56: 3038-41
49. 49. Burfeind P, Chernicky CL, Rininsland F, Ilan J, Ilan J. Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc Natl Acad Sci USA 1996; 93: 7263-8
50. 50. Pass HI, Mew DJ, Carbone M, Matthews WA, Donington JS, Baserga R, Walker CL, Resnicoff M, Steinberg SM. Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-I receptor. Cancer Res 1996; 56: 4044-8
51. 51. Blakesley VA, Kalebic T, Helman LJ, Stannard B, Faria TN, Roberts CT Jr, LeRoith D. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxyterminus of the IGF-I receptor. Endocrinology 1996; 137: 410-7
52. 52. Kalebic T, Blakesley V, Slade C, Plasschaert S, LeRoith D, Helman LJ. Expression of a kinase-deficient IGF-I-R suppresses tumorigenicity of rhabdomyosarcoma cells constitutively expressing a wild type IGF-I-R. Int J Cancer 1998; 76: 223-7
53. 53. Kalebic T, Tsokos M, Helman LJ. In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2. Cancer Res 1994; 54: 5531-4
54. 54. Doerr ME, Jones JI. The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells. J Biol Chem 1996; 271 : 2443-7
55. 55. Pollak M, Richard M. Suramin blockade of insulin-like growth factor I-stimulated proliferation of human osteosarcoma cells. J Natl Cancer Inst 1990; 82: 1349-52
56. 56. Minniti CP, Maggi M, Helman LJ. Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine loop. Cancer Res 1992; 52: 1830-5
57. 57. Thulasi R, Dias P, Houghton PJ, Houghton JA. Alpha 2a-interferon-induced differentiation of human alveolar rhabdomyosarcoma cells: correlation with down-regulation of the insulin-like growth factor type I receptor. Cell Growth Differ 1996; 7: 531-41